(Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an...

62
(Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Transcript of (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an...

Page 1: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

(Relates to Chapter 16, “Cancer,” in the textbook)

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 2: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

2

Group of more than 200 diseases

Characterized by uncontrolled and unregulated growth of cells

Occurs in people of all ethnic groups and all ages

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 3: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

3

~1,450,000 persons diagnosed with cancer in 2006 Excluding basal and squamous cell skin cancers▪ More than 1 million cases of basal and squamous cell skin cancer annually

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 4: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

4

Incidences of lung, colorectal, and oral cancer have ↓

Other cancers have ↑ Non-Hodgkin’s lymphoma Skin cancer

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 5: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

5

Higher in men than womenIncidence and death rates

are higher in African Americans than in whites and other minorities.

Second most common cause of death in the United States after heart disease

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 6: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

6

5-Year survival rate is now 66% for those who are Disease free In remission Under treatment Does not include number of people who are “cured” of cancer

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 7: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

7

Most human tissues contain predetermined, undifferentiated stem cells.

Predetermined stem cells give rise to mature cells of the type of tissue where they reside.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 8: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.8

Fig. 16-1. Cell life cycle and metabolic activity. Generation time is the period from M phase to M phase. Cells not in the cycle but capable of division are in the resting phase (G0).

Page 9: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

9

All cells are controlled by an intracellular mechanism that determines proliferation.

Cancer cells grown in culture are characterized by loss of contact inhibition. Grow on top of one another and on top of or between normal cells

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 10: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

10

Cancer cells respond differently than normal cells to intracellular signals regulating equilibrium. Divide indiscriminately

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 11: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

11

Stem cell theory Loss of intracellular control of proliferation results from mutation of stem cells.

DNA is substituted or permanently rearranged.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 12: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

12

Once mutated Cells can die from damage or by initiating programmed cellular suicide (apoptosis).

Can recognize damage and repair itself

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 13: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

13

Once mutated (cont’d) Can survive and pass on damage to two or more daughter cells

Surviving mutated cells have potential to become malignant.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 14: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

14

Orderly process progressing from a state of immaturity to a state of maturity

Stable and will not changeExact mechanism of normal

cellular differentiation is not completely understood.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 15: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

15Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Fig. 16-2. Normal cellular differentiation.

Page 16: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

16

Two types of genes that can be affected by mutation are

1. Protooncogenes ▪ Regulate normal cellular

processes such as promoting growth

2. Tumor suppressor genes ▪ Suppress growth

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 17: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

17

Protooncogenes Genetic locks that keep cells functioning normally

Mutations that alter their expression can activate them to function as oncogenes.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 18: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

18

Tumor suppressor genes Function to regulate cell growth

Suppress growth of tumors Mutations render them inactive.

Result in loss of suppression of tumor growth

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 19: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

19

Tumors can be classified as benign or malignant neoplasms

Benign neoplasm Well differentiated Usually encapsulated Expansive mode of growth

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 20: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

20

Benign neoplasm (cont’d) Characteristics similar to parent cell

Metastasis is absent. Rarely recur

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 21: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

21

Malignant neoplasm May range from well differentiated to undifferentiated

Able to metastasize Infiltrative and expansive growth

Frequent recurrence

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 22: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

22

Malignant neoplasm (cont’d) Moderate to marked vascularity Rarely encapsulated Becomes less like parent cell

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 23: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

23

Likely to be multifactorialOrigin of cancer may be

Genetic Chemical Environmental Viral or immunologic May arise from causes not yet identified

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 24: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

24Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Fig. 16-3. Process of cancer development.

Page 25: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

25

Initiation Mutation of cell’s genetic structure▪ From inherited mutation▪ From exposure to a chemical, radiation, or viral agent

Mutated cell has the potential to develop into clone of neoplastic cells.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 26: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

26

Initiation (cont’d) Once initiated, mutation is irreversible.

Not all mutated cells form a tumor.

Mutated cells become tumors only when they establish the ability to self-replicate and grow.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 27: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

27

Initiation (cont’d) Carcinogens may be

▪ Chemical▪ Radiation▪ Viral

Carcinogens can be ▪ Detoxified ▪ Harmlessly excreted

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 28: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

28

Initiation (cont’d) Cells damaged by carcinogens may ▪ Self-repair▪ Die▪ Replicate into daughter cells with same genetic alteration

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 29: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

29

Chemical carcinogens Long latency period makes identification of carcinogens difficult.

Animal studies may not apply to humans.

Certain drugs have been identified as carcinogens.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 30: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

30

Radiation Ionizing radiation can cause cancer in almost any human tissue.

Dose of radiation needed to cause cancer is unknown.

Ultraviolet radiation is associated with melanoma and squamous and basal cell carcinoma.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 31: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

31

Viral carcinogensVirus Associated Cancer

Epstein-Barr virus (EBV) Burkitt’s lymphoma

Human immunodeficiency virus (HIV)

Kaposi sarcoma

Hepatitis B virus Hepatocellular carcinoma

Human papillomavirus Squamous cell carcinomas

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 32: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

32

Promotion Characterized by reversible proliferation of altered cells

Activities of promotion are reversible.▪ Obesity▪ Smoking, alcohol▪ Dietary fat

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 33: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

33

Latent period May range from 1 to 40 years Length of latent period associated with mitotic rate of tissue of origin and environmental factors

For disease to be clinically evident, tumor must reach a critical mass that can be detected.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 34: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

34

Progression Characterized by

▪ Increased growth rate of tumor▪ Invasiveness▪ Metastasis

Most frequent sites of metastasis are lungs, brain, bone, liver, and adrenal glands.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 35: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

35Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Fig. 16-4. Main sites of metastasis.

Page 36: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

36Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Fig. 16-5. The pathogenesis of cancer metastasis. To produce metastases, tumor cells must detach from the primary tumor and enter the circulation, survive in the circulation to arrest in the capillary bed, adhere to capillary basement membrane, gain entrance into the organ parenchyma, respond to growth factors, proliferate and induce angiogenesis, and evade host defenses.

Page 37: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

37

Progression (cont’d) Metastasis process begins with rapid growth of primary tumor.▪ Develops its own blood supply

▪ Critical for survival and growth of tumor▪ Tumor angiogenesis is formation of blood vessels within tumor.

▪ Certain segments of primary tumor can detach and invade surrounding tissues.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 38: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

38

Progression (cont’d) Metastasis process (cont’d)

▪ Detached cells can invade lymph nodes and vascular vessels to travel to distant sites.

▪ Most mobile tumor cells do not survive.

▪ Surviving tumor cells must create an environment conducive to growth and development.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 39: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

39

Immune response is to reject or destroy cancer cells. May be inadequate as cancer cells arise from normal human cells

Some cancer cells have changes on their surface antigens. Tumor-associated antigens (TAAs)

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 40: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

40Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Fig. 16-6. Tumor-associated antigens appear on the cell surface of malignant cells.

Page 41: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

41

Immunologic surveillance Response to TAAs Lymphocytes continually check cell surface antigens and detect and destroy abnormal cells.

Involves cytotoxic T cells, natural killer cells, macrophages, and B lymphocytes

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 42: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

42

Cytotoxic T cells Kill tumor cells directly Produce cytokines

Natural killer cells and activated macrophages can lyse tumor cells.

B cells produce antibodies directed to tumor surface antigens.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 43: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

43

Immunologic escape Mechanism by which cancer cells evade immune system ▪ Suppression of factors that stimulate T cells

▪ Weak surface antigens allow cancer cells to “sneak through” surveillance.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 44: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

44

Immunologic escape (cont’d)▪ Develops tolerance to immune system by some tumor antigens

▪ Suppresses immune response from products secreted by cancer cells

▪ Induction of suppressor T cells ▪ Blocking antibodies bind TAAs, preventing recognition

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 45: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

45Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Fig. 16-7. Blocking antibodies prevent T cells from interacting with tumor-associated antigens and from destroying the malignant cell.

Page 46: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

46

Oncofetal antigens Found on tumor cell surfaces, inside tumor cells, and fetal cells

Appearance of fetal antigens is not well understood.

May result as cell regains its embryonic capability to differentiate into many cell types

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 47: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

47

Examples of oncofetal antigens Carcinoembryonic antigen (CEA)

▪ On cancer cells of GI tract▪ Normal cells (fetal gut, liver, and pancreas)

α-Fetoprotein (AFP)▪ Malignant liver cells and fetal liver cells

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 48: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

48

Examples of oncofetal antigens (cont’d) CA-125 CA-19-9 Prostate-specific antigen (PSA) CA 15-3, CA 27-29 kRAS HER-2

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 49: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

49

Tumors can be classified by Anatomic site Histology

▪ Grading severity Extent of disease

▪ Staging

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 50: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

50

Classification systems provide a standardized way to Communicate with health care team

Prepare and evaluate treatment plan

Determine prognosis Compare groups statistically

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 51: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

51

Anatomic site classification Identified by tissue of origin Carcinomas originate from

▪ Embryonal ectoderm (skin, glands) ▪ Endoderm (mucous membrane of respiratory tract, GI and GU tracts)

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 52: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

52

Anatomic site classification (cont’d) Sarcomas originate from

▪ Embryonal mesoderm (connective tissue, muscle, bone, and fat)

Lymphomas and leukemias originate from ▪ Hematopoietic system

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 53: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

53

Histologic classification Appearance of cells and degree of differentiation are evaluated to determine how closely cells resemble tissue of origin.

Poorly differentiated tumors have a worse prognosis than those closer in appearance to normal cells.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 54: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

54

Four grades of abnormal cells Grade I

▪ Cells differ slightly from normal cells and are well differentiated.

Grade II▪ Cells are more abnormal and moderately differentiated.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 55: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

55

Four grades (cont’d) Grade III

▪ Cells are very abnormal and poorly differentiated.

Grade IV▪ Cells are immature and primitive and undifferentiated.

▪ Cell of origin is difficult to determine.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 56: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

56

Clinical staging classifications 0: Cancer in situ 1: Tumor limited to tissue of origin; localized tumor growth

2: Limited local spread 3: Extensive local and regional spread

4: Metastasis

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 57: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

57

TNM classification system Anatomic extent of disease is based on three parameters:▪ Tumor size and invasiveness (T)▪ Spread to lymph nodes (N)▪ Metastasis (M)

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 58: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

58

Lifestyle habits to reduce risks: Avoid or reduce exposure to known or suspected carcinogens. ▪ Cigarette smoke, excessive sun exposure

Eat a balanced diet. Exercise regularly. Obtain adequate rest.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 59: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

59

Habits to reduce risks (cont’d) Have a regular health examination. Change perceptions of stressors. Know seven warning signs of cancer.

Practice recommended cancer screenings.

Practice self-examination. Seek medical care if cancer is suspected.

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 60: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

60

Patient may experience fear and anxiety.

Nurse should Give clear explanations, repeat if necessary

Give written information for reinforcement

Actively listen to patient’s concerns

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 61: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

61

Diagnostic plan includes Health history Identification of risk factors Physical examination Specific diagnostic studies

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

Page 62: (Relates to Chapter 16, “Cancer,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.

62

Indicated diagnostic studies depend on site of cancer. Biopsy involves histologic examination by a pathologist of a piece of tissue.▪ Tissue may be obtained by

▪ Needle or aspiration ▪ Incisional procedure ▪ Excisional procedure

Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.